SCHEMBL320843

SCHEMBL320843

Nc1ccc2occc2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 6/20 0.55
CDK9 P50750 1/20 0.55
CYP2A6 P11509 2/20 0.50
FLT3 P36888 1/20 0.44
ADORA2A P29274 2/20 0.44
ADORA1 P30542 1/20 0.44
CA2 P00918 2/20 0.42
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTR1B P28222 2/20 0.41
EPM2A O95278 1/20 0.41
PTPRC P08575 1/20 0.41
PTPN6 P29350 1/20 0.41
CDC14A Q9UNH5 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
NPC1 O15118 1/20 0.41
CTNNB1 P35222 1/20 0.40
WNT3A P56704 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31506768 1.00 DYRK1A (0.55) DYRK1ACDK9CYP2A6FLT3ADORA2A
Hydrochloric Acid SCHEMBL10508897 0.98 DYRK1A (0.53) DYRK1ACDK9CYP2A6FLT3ADORA2A
Methane SCHEMBL22289615 0.98 DYRK1A (0.53) DYRK1ACDK9CYP2A6FLT3ADORA2A
Butane SCHEMBL27886823 0.88 DYRK1A (0.46) DYRK1ACDK9CYP2A6ADORA2AADORA1
SCHEMBL596878 0.81 CYP3A4 (0.44) DYRK1ACDK9CYP2A6CA2ALDH1A1
SCHEMBL30469316 0.80 DYRK1A (0.64) DYRK1ACDK9ADORA2AADORA1CA2
SCHEMBL20557314 0.80 DYRK1A (0.64) DYRK1ACDK9ADORA2AADORA1CA2
SCHEMBL28156511 0.79 CYP3A4 (0.42) DYRK1ACDK9CYP2A6CA2ALDH1A1
Ethoxycarbonyl Group SCHEMBL27907131 0.79 CYP2A6 (0.45) DYRK1ACDK9CYP2A6CA2HTR1B
Benzofuran SCHEMBL9494180 0.74 CYP3A4 (0.42) DYRK1ACDK9ADORA2AADORA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117143085-A ABS heat-resistant modifier, intermediate, high-temperature-resistant ABS material and preparation method 四川轻化工大学 2023-12-01 CN claimed
CN-109134267-B Synthetic method of aromatic amine compound 北京大学 2020-11-17 CN claimed
US-20200035418-A1 PASSIVATION OF DEFECTS IN PEROVSKITE MATERIALS FOR IMPROVED SOLAR CELL EFFICIENCY AND STABILITY NUTECH VENTURES 2020-01-30 US claimed
CN-109134267-A A kind of synthetic method of aromatic amine compounds 北京大学 2019-01-04 CN claimed
WO-2018152494-A1 PASSIVATION OF DEFECTS IN PEROVSKITE MATERIALS FOR IMPROVED SOLAR CELL EFFICIENCY AND STABILITY NUTECH VENTURES (US) 2018-08-23 WO claimed
US-20130317100-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK PHARMACEUTICALS D.D. (SI) 2013-11-28 US claimed
EP-2638024-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK Pharmaceuticals d.d. (SI) 2013-09-18 EP claimed
EP-2552900-A1 PROCESS FOR PREPARING AMINOBENZOFURAN DERIVATIVES SANOFI (FR) 2013-02-06 EP claimed
US-20130023677-A1 PROCESS FOR PREPARING AMINOBENZOFURAN DERIVATIVES SANOFI (FR) 2013-01-24 US claimed
WO-2012062918-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK PHARMACEUTICALS D.D. (SI) 2012-05-18 WO claimed
EP-2452938-A1 Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives LEK Pharmaceuticals d.d. (SI) 2012-05-16 EP claimed
WO-2011121245-A1 PROCESS FOR PREPARING AMINOBENZOFURAN DERIVATIVES SANOFI-AVENTIS (FR) 2011-10-06 WO claimed
EP-1351907-B1 2-BUTYL-3-(4- 3(DIBUTYLAMINO)PROPOXY BENZOYL)-5-NITRO-BENZOFURAN HYDROCHLORIDE AND PREPARATION THEREOF SANOFI AVENTIS (FR) 2006-11-15 EP claimed
US-6846936-B2 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof SANOFI-SYNTHELABO (FR) 2005-01-25 US claimed
US-20040010032-A1 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof SANOFI (FR) 2004-01-15 US claimed
EP-1351907-A1 2-BUTYL-3-(4- 3(DIBUTYLAMINO)PROPOXY BENZOYL)-5-NITRO-BENZOFURAN HYDROCHLORIDE AND PREPARATION THEREOF Sanofi-Aventis (FR) 2003-10-15 EP claimed
WO-2002048078-A1 2-BUTYL-3-(4-[3(DIBUTYLAMINO)PROPOXY]BENZOYL)-5-NITRO-BENZOFURAN HYDROCHLORIDE AND PREPARATION THEREOF SANOFI-SYNTHELABO (FR) 2002-06-20 WO claimed
EP-4716529-A2 COMPOUNDS THAT RE-ACTIVATE MUTANT P53 Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center (US) 2026-04-01 EP disclosed
US-3963717-A ANTIINFLAMMATORY, ANALGESIC SANDOZ, INC. (US) 1976-06-15 US disclosed
US-3957860-A SULFAMIC ACID CIBA-GEIGY AG (CH) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023677-A1 PROCESS FOR PREPARING AMINOBENZOFURAN DERIVATIVES CYP2F1, F5, F12 DYRK1A 3394/4885CDK9 2726/4885CYP2A6 259/4885
US-20130317100-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES CYP3A5, CYP4F3, CYP3A4 DYRK1A 3601/4885CDK9 1641/4885CYP2A6 33/4885
US-20040010032-A1 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof CYP2D6, DBF4, DUT DYRK1A 1989/4885CDK9 3321/4885CYP2A6 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.